Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCG2 | Q9UNQ0 | 6/20 | 0.79 |
| ▸ | ABCB1 | P08183 | 5/20 | 0.79 |
| ▸ | MAPT | P10636 | 7/20 | 0.76 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.76 |
| ▸ | GAA | P10253 | 2/20 | 0.76 |
| ▸ | TUBB4A | P04350 | 2/20 | 0.63 |
| ▸ | TUBB | P07437 | 2/20 | 0.63 |
| ▸ | TUBA3C | P0DPH7 | 2/20 | 0.63 |
| ▸ | TUBA1B | P68363 | 2/20 | 0.63 |
| ▸ | TUBA4A | P68366 | 2/20 | 0.63 |
| ▸ | TUBB4B | P68371 | 2/20 | 0.63 |
| ▸ | TUBB3 | Q13509 | 2/20 | 0.63 |
| ▸ | TUBB2A | Q13885 | 2/20 | 0.63 |
| ▸ | TUBB8 | Q3ZCM7 | 2/20 | 0.63 |
| ▸ | TUBA3E | Q6PEY2 | 2/20 | 0.63 |
| ▸ | TUBA1A | Q71U36 | 2/20 | 0.63 |
| ▸ | TUBA1C | Q9BQE3 | 2/20 | 0.63 |
| ▸ | TUBB6 | Q9BUF5 | 2/20 | 0.63 |
| ▸ | TUBB2B | Q9BVA1 | 2/20 | 0.63 |
| ▸ | TUBB1 | Q9H4B7 | 2/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Natsudaidai SCHEMBL30402919 | 1.00 | ABCG2 (0.79) | ABCG2ABCB1MAPTKDM4EGAA | |
| Natsudaidai SCHEMBL31237778 | 1.00 | ABCG2 (0.79) | ABCG2ABCB1MAPTKDM4EGAA | |
| Natsudaidai SCHEMBL29486468 | 1.00 | ABCG2 (0.79) | ABCG2ABCB1MAPTKDM4EGAA | |
| SCHEMBL24895133 | 0.89 | KDM4E (0.67) | ABCG2ABCB1MAPTKDM4EGAA | |
| 3,5,6,7,8,3',4'-Heptamethoxyflavone SCHEMBL1764676 | 0.88 | ABCG2 (1.00) | ABCG2ABCB1MAPTKDM4EGAA | |
| 3,5,6,7,8,3',4'-Heptamethoxyflavone SCHEMBL29467229 | 0.88 | ABCG2 (1.00) | ABCG2ABCB1MAPTKDM4EGAA | |
| 3,5,6,7,8,3',4'-Heptamethoxyflavone SCHEMBL31621487 | 0.88 | ABCG2 (1.00) | ABCG2ABCB1MAPTKDM4EGAA | |
| SCHEMBL31511429 | 0.86 | KDM4E (0.82) | ABCG2ABCB1MAPTKDM4EGAA | |
| SCHEMBL1764666 | 0.86 | KDM4E (0.82) | ABCG2ABCB1MAPTKDM4EGAA | |
| SCHEMBL507435 | 0.86 | MAPT (1.00) | ABCG2ABCB1MAPTKDM4EGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 663 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3346842-B1 | STABLE INOCULANT COMPOSITIONS AND METHODS FOR PRODUCING SAME | NOVONESIS PLANT BIOSOLUTIONS AS (DK) | 2026-03-25 | — | — | EP | claimed |
| WO-2025235852-A1 | FLAVONOID COMPOSITIONS AND METHODS OF USE | SYNGENTA CROP PROTECTION AG (CH) | 2025-11-13 | — | — | WO | claimed |
| WO-2025038482-A2 | USE OF FISETIN FOR REDUCING THE INCIDENCE OF ATRIAL FIBRILLATION | RHODE ISLAND HOSPITAL (US) | 2025-02-20 | — | — | WO | claimed |
| CN-119470756-A | UPLC quantitative fingerprint detection method for camphor head red tangerine peel | 赣江中药创新中心 | 2025-02-18 | — | — | CN | claimed |
| CN-118091005-A | Method for detecting multiple components in deer astragalus kidney-tonifying particles | 上海市第七人民医院(上海中医药大学附属第七人民医院) | 2024-05-28 | — | — | CN | claimed |
| US-11560342-B2 | Bacillus isolates and uses thereof | MONSANTO TECHNOLOGY, LLC (US) | 2023-01-24 | — | — | US | claimed |
| WO-2022194862-A1 | METHOD FOR PREDICTING THE LIKELIHOOD OF PREGNANCY IN FEMALE MAMMALS WHICH EXPERIENCE AN ESTROUS CYCLE | BREEDSENSE AS (NO) | 2022-09-22 | — | — | WO | claimed |
| EP-3801030-A1 | METHODS OF PROTECTING A PLANT FROM FUNGAL PESTS | Novozymes BioAG A/S (DK) | 2021-04-14 | — | — | EP | claimed |
| EP-3801017-A1 | METHODS OF PROTECTING A PLANT FROM INSECT PESTS | Novozymes Bioag A/S (DK) | 2021-04-14 | — | — | EP | claimed |
| US-20210068401-A1 | BACILLUS ISOLATES AND USES THEREOF | MONSANTO TECHNOLOGY LLC (US) | 2021-03-11 | — | — | US | claimed |
| WO-2017044545-A1 | STABLE INOCULANT COMPOSITIONS AND METHODS FOR PRODUCING SAME | NOVOZYMES BIOAG A/S (DK) | 2017-03-16 | — | — | WO | claimed |
| WO-2017033060-A1 | COMPOSITION FOR TREATING DRY EYE DISEASES AND SJÖGREN'S SYNDROME | UNIVERSITY OF MACAU (CN) | 2017-03-02 | — | — | WO | claimed |
| US-20150196529-A1 | USE OF FLAVONE AND FLAVANONE DERIVATIVES IN PREPARATION OF SEDATIVE AND HYPNOTIC DRUGS | JIN YONGRI (CN) | 2015-07-16 | — | — | US | claimed |
| EP-2736484-A1 | BOTANICAL ANTIOXIDANT COMPOSITIONS AND METHODS OF PREPARATION AND USE THEREOF | US CosmeceuTechs LLC (US) | 2014-06-04 | — | — | EP | claimed |
| US-20140039044-A1 | Hydroxylated Polymethoxyflavone Compositions | WLLGEN, INC. (US) | 2014-02-06 | — | — | US | claimed |
| EP-2665467-A2 | FLAVONOL COMPOSITIONS | Ono, Mitsunori (US) | 2013-11-27 | — | — | EP | claimed |
| WO-2013016257-A1 | BOTANICAL ANTIOXIDANT COMPOSITIONS AND METHODS OF PREPARATION AND USE THEREOF | US COSMECEU TECHS LLC (US) | 2013-01-31 | — | — | WO | claimed |
| WO-2012099930-A2 | FLAVONOL COMPOSITIONS | ONO MITSUNORI (US) | 2012-07-26 | — | — | WO | claimed |
| US-20120183587-A1 | FLAVONOL COMPOSITIONS | LINES, THOMAS CHRISTIAN (CH) | 2012-07-19 | — | — | US | claimed |
| US-20070275106-A1 | Hydroxylated polymethoxyflavone compositions | WELLGEN, INC. | 2007-11-29 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210068401-A1 | BACILLUS ISOLATES AND USES THEREOF | BLVRB, BROX, GLB1 | ABCG2 2702/4885ABCB1 3779/4885MAPT 738/4885 |
| US-20120183587-A1 | FLAVONOL COMPOSITIONS | CYP2F1, F3, TEAD3 | ABCG2 101/4885ABCB1 1660/4885MAPT 1698/4885 |
| US-11560342-B2 | Bacillus isolates and uses thereof | BLVRB, BROX, GLB1 | ABCG2 2702/4885ABCB1 3779/4885MAPT 738/4885 |
| US-20070275106-A1 | Hydroxylated polymethoxyflavone compositions | PLIN5, FANCF, COXFA4 | ABCG2 2685/4885ABCB1 3019/4885MAPT 4329/4885 |
| US-20150196529-A1 | USE OF FLAVONE AND FLAVANONE DERIVATIVES IN PREPARATION OF SEDATIVE AND HYPNOTIC DRUGS | CYP2D6, GATAD2A, CYP3A43 | ABCG2 98/4885ABCB1 218/4885MAPT 1508/4885 |
| US-20140039044-A1 | Hydroxylated Polymethoxyflavone Compositions | PLIN5, FANCF, COXFA4 | ABCG2 2685/4885ABCB1 3019/4885MAPT 4329/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.